Abstract:Sustaining efficacious T cell-mediated antitumor immune responses in the tumor tissues is the key to the success of cancer immunotherapy. Current strategies leverage altering the signals T cells sense in the tumor microenvironment (TME). Checkpoint inhibitor-based approaches block inhibitory signals such as PD-1 whereas cytokine-based therapies increase the level of immune-stimulatory cytokines such as IL-2. Besides extrinsic signals, the genetic circuit within T cells also participates in determining the nature and trajectory of antitumor immune responses. Here, we showed that efficacy of the IL33-based tumor immunotherapy was greatly enhanced in mice with T cell-specific Eomes deficiency. Mechanistically, we demonstrated that Eomes deficient mice had diminished proportions of exhausted/dysfunctional CD8+ T cells but increased percentages of tissue resident and stem-like CD8+ T cells in the TME. In addition, the IFNγ+TCF1+ CD8+ T cell subset was markedly increased in the Eomes deficient mice. We further demonstrated that Eomes bound directly to the transcription regulatory regions of exhaustion and tissue residency genes. In contrast to its role in inhibiting T cell immune responses at the tumor site, Eomes promoted generation of central memory T cells in the peripheral lymphoid system and memory recall responses against tumor growth at a distal tissue site. Finally, we showed that Eomes deficiency in T cells also resulted in increased efficacy of PD-1-blockade tumor immunotherapy. In all, our study indicates that Eomes plays a critical role in restricting prolonged T cell-mediated antitumor immune responses in the TME whereas promoting adaptive immunity in peripheral lymphoid organs.

TGF-β and Eomes Control the Homeostasis of CD8+ Regulatory T Cells

TGF-β–Induced Regulatory T Cells Directly Suppress B Cell Responses Through a Noncytotoxic Mechanism

Generation and Regulation of CD8(+) Regulatory T Cells.

Inhibition of follicular T-helper cells by CD8 + regulatory T cells is essential for self tolerance

Immune Homeostasis Enforced by Co-Localized Effector and Regulatory T Cells

Regulation Of Cd8(+) Regulatory T Cells: Interruption Of The Nkg2a-Qa-1 Interaction Allows Robust Suppressive Activity And Resolution Of Autoimmune Disease

Tcf1 and Lef1 Are Required for the Immunosuppressive Function of Regulatory T Cells

T-Bet and Eomes Regulate the Balance between the Effector/Central Memory T Cells versus Memory Stem Like T Cells.

Autocrine TGF-β1 Maintains the Stability of Foxp3+ Regulatory T Cells via IL-12Rβ2 Downregulation

Phenotypic and Functional Characteristic of Newly Identified CD8+Foxp3-CD103+ Regulatory T Cells (P1047)

TGF-beta controls development of TCR gamma delta(+)CD8 alpha alpha(+) intestinal intraepithelial lymphocytes

TGF-β controls development of TCRγδ+CD8αα+ intestinal intraepithelial lymphocytes

Transforming Growth Factor-Beta: an Important Role in CD4+CD25+ Regulatory T Cells and Immune Tolerance.

Phenotypic and Functional Characteristic of a Newly Identified CD8+ Foxp3- CD103+ Regulatory T Cells.

FOXP3 Exon 2 Controls Treg Stability and Autoimmunity

Caspase-8 has dual roles in regulatory T cell homeostasis balancing immunity to infection and collateral inflammatory damage

FOXP3 exon 2 controls T reg stability and autoimmunity

Transcription factor EB coordinates environmental cues to regulate T regulatory cells' mitochondrial fitness and function.

Eomes Impedes Durable Response to Tumor Immunotherapy by Inhibiting Stemness, Tissue Residency, and Promoting the Dysfunctional State of Intratumoral CD8+ T Cells.

The Transcription Factors Egr2 and Egr3 Are Essential for the Control of Inflammation and Antigen-Induced Proliferation of B and T Cells

Control of T reg cell homeostasis and immune equilibrium by Lkb1 in dendritic cells